A plasma microRNA panel for early detection of colorectal cancer

International Journal of Cancer

Volumn 136, Issue 1, 2015, Pages 152-161

  Wang, Shuyang ^a   Xiang, Jianbin ^b   Li, Zhaoyong ^a,c   Lu, Shaohua ^a   Hu, Jie ^a   Gao, Xue ^a   Yu, Lei ^a   Wang, Lei ^a   Wang, Jiping ^d   Wu, Ying ^a   Chen, Zongyou ^b   Zhu, Hongguang ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

colorectal cancer; colorectal cancer genes; microRNA

Indexed keywords

MICRORNA; MICRORNA 25; MICRORNA 331 3P; MICRORNA 345; MICRORNA 409 3P; MICRORNA 671 3P; MICRORNA 7; MICRORNA 92A; MICRORNA 93; UNCLASSIFIED DRUG; TRANSCRIPTOME; TUMOR MARKER;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; CANCER SCREENING; CANCER STAGING; COHORT ANALYSIS; COLON METASTASIS; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; COLORECTAL NEOPLASMS; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; MIDDLE AGED; MOLECULAR DIAGNOSIS; MULTICENTER STUDY;

ADULT; AGED; AREA UNDER CURVE; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROC CURVE; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84923082567     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28136     Document Type: Article

References (50)

1. Jemal A, Bray F, Center MM, et al., Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Anwar R,. Screening for colorectal cancer in the UK. Digest Liver Dis 2006; 34: 279-82.
3. Gili M, Roca M, Ferrer V, et al., Psychosocial factors associated with the adherence to a colorectal cancer screening program. Cancer Detect Prev 2006; 30: 354-60.
4. Bleiker EM, Menko FH, Taal BG, et al., Screening behavior of individuals at high risk for colorectal cancer. Gastroenterology 2005; 128: 280-7.
5. Nicholson FB, Korman MG,. Acceptance of flexible sigmoidoscopy and colonoscopy for screening and surveillance in colorectal cancer prevention. J Med Screen 2005; 12: 89-95.
6. Nicholson FB, Barro JL, Atkin W, et al., Review article: population screening for colorectal cancer. Aliment Pharmacol Ther 2005; 22: 1069-77.
7. Wee CC, McCarthy EP, Phillips RS,. Factors associated with colon cancer screening: the role of patient factors and physician counselling. Prev Med 2005; 41: 23-9.
8. Seeff LC, Nadel MR, Klabunde CN, et al., Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer 2004; 100: 2093-103.
9. Nelson DB, Muscarella LF,. Current issues in endoscope reprocessing and infection control during gastrointestinal endoscopy. World J Gastroenterol 2006; 12: 3953-64.
10. Burdick JS, Hambrick D,. Endoscope reprocessing and repair costs. Gastrointest Endosc Clin N Am 2004; 14: 717-24.
11. Littlejohn C, Hilton S, Macfarlane GJ, et al., Systematic review and meta-analysis of the evidence for flexible sigmoidoscopy as a screening method for the prevention of colorectal cancer. Br J Surg 2012; 99: 1488-500.
12. Glick S,. Double-contrast barium enema for colorectal cancer screening: a review of the issues and a comparison with other screening alternatives. Am J Roentgenol 2000; 174: 1529-37.
13. Sabanli M, Balasingam A, Bailey W, et al., Computed tomographic colonography in the diagnosis of colorectal cancer. Br J Surg 2010; 97: 1291-4.
14. Mandel JS, Church TR, Bond JH, et al., The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343: 1603-7.
15. Thomas P, Toth CA, Saini KS, et al., The structure, metabolism and function of the carcinoembryonic antigen gene family. Biochim Biophys Acta 1990; 1032: 177-89.
16. Duffy MJ,. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem 2001; 47: 624-30.
17. Michael MZ, O' Connor SM, van Holst Pellekaan NG, et al., Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003; 1: 882-91.
18. Bandrés E, Cubedo E, Agirre X, et al., Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 2006; 5: 29.
19. Schepeler T, Reinert JT, Ostenfeld MS, et al., Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 2008; 68: 6416-24.
20. Schetter AJ, Leung SY, Sohn JJ, et al., MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008; 299: 425-36.
21. Mitchell PS, Parkin RK, Kroh EM, et al., Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105: 10513-18.
22. Chen X, Ba Y, Ma L, et al., Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18: 997-1006.
23. Ng EK, Chong WW, Jin H, et al., Differential expression of microRNAs in plasma of patients with colorectal cancer a potential marker for colorectal cancer screening. Gut 2009; 58: 1375-81.
24. Huang Z, Huang D, Ni S, et al., Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010; 127: 118-26.
25. Cheng H, Zhang L, Cogdell DE, et al., Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS ONE 2011; 6: e17745.
26. Hamilton SR, Aaltonen LA,. World Health Organization classification of tumors: tumours of the colon and rectum. Pathology and genetics of tumors of digestive system. Lyon: IARC Press, 2003. 103-42.
27. Dukes CE,. The classification of cancer of the rectum. J Pathol Bacteriol 1932; 35: 323.
28. Kozomara A, Griffiths-Jones S,. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011; 9: D152-7.
29. Zhou J, Yu L, Gao X, et al., A Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol 2011; 29: 4781-8.
30. Bustin SA, Benes V, Garson JA, et al., The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009; 55: 611-22.
31. Mann HB, Whitney DR,. On a test of whether one of two random variables is stochastically larger than the other. Ann Math Stat 1947; 18: 50-60.
32. DeLong ER, DeLong DM, Clarke-Pearson DL,. Comparing the areas under 2 or more correlated receiver operating characteristic curves-a nonparametric approach. Biometrics 1988; 44: 837-45.
33. Hanley JA, McNeil BJ,. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839-43.
34. Bond JH,. Colon polyps and cancer. Endoscopy 2003; 35: 27-35.
35. Stewart BW, Kleihus P, eds. World cancer report. Lyon: IARC Press, 2003.
36. National Cancer Institute. Cancer statistics review, 1973-88. Bethesda, MD: National Cancer Institute, 1991.
37. Wilson LS, Lightwood J,. Model of estimated rates of colorectal cancer from polyp growth by year of surveillance. J Med Screen 2001; 8: 187-96.
38. Shida H, Ban K, Matsumoto M, et al., Asymptomatic colorectal cancer detected by screening. Dis Colon Rectum 1996; 39: 1130-5.
39. Kitamura K, Taniguchi H, Yamaguchi T, et al., Clinical outcome of surgical treatment for invasive early colorectal cancer in Japan. Hepato-gastroenterology 1997; 44: 108-15.
40. Hardcastle JD, Chamberlain JO, Robinson MH, et al., Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-7.
41. Smith GA, Oien KA, O'Dwyer PJ,. Frequency of early colorectal cancer in patients undergoing colonoscopy. Br J Surg 1999; 86: 1328-31.
42. Kalra L, Price WR, Jones BJM, et al., Open access fibre sigmoidoscopy: a comparative audit of efficiency. Br Med J 1988; 296: 1095-6.
43. Sharaf RN, Ladabaum U,. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies. Am J Gastroenterol 2013; 108: 120-32.
44. Bresalier RA, Boland CR, Itzkowitz SH, et al., Basic gastrointestinal oncology. In:, Kern F Jr, Blum AL, eds. The gastroeneterology annual/2. Amsterdam: Elsevier/North Holland, 1989. 271-319.
45. Chen X, Ba Y, Ma L, et al., Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18: 997-1006.
46. Wang S, Wang L, Bayaxi N, et al., A microRNA panel to discriminate carcinomas from high grade intraepithelial neoplasms in colonoscopy biopsy tissues. Gut 2013; 62: 280-9.
47. Wang S, Wang L, Zhu T, et al., Improvement of tissue preparation for laser capture microdissection: application for cell type-specific miRNA expression profiling incolorectal tumor. BMC Genomics 2010; 11: 163.
48. Yang IP, Tsai HL, Hou MF, et al., MicroRNA-93 inhibits tumor growth and early relapse of human colorectal cancer by affecting genes involved in the cell cycle. Carcinogenesis 2012; 33: 1522-30.
49. Zheng B, Liang L, Huang S, et al., MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers. Oncogene 2012; 31: 4509-16.
50. Li C, Nie H, Wang M, et al., MicroRNA-409-3p regulates cell proliferation and apoptosis by targeting PHF10 in gastric cancer. Cancer Lett 2012; 320: 189-97.